Complete remission in a patient with multifocal metastatic cutaneous angiosarcoma with a combination of paclitaxel and sorafenib

被引：21
作者：
Donghi, D. [1 ]
Dummer, R. [1 ]
Cozzio, A. [1 ]
机构：
[1] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2010年 / 162卷 / 03期
关键词：
angiosarcoma; metastasis; paclitaxel; remission; sorafenib;
D O I：
10.1111/j.1365-2133.2009.09607.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：697 / 699
页数：4
相关论文
共 10 条
[1]   Treatment and outcome of 82 patients with angiosarcoma [J].
Abraham, John A. ;
Hornicek, Francis J. ;
Kaufman, Adam M. ;
Harmon, David C. ;
Springfield, Dempsey S. ;
Raskin, Kevin A. ;
Mankin, Henry J. ;
Kirsch, David G. ;
Rosenberg, Andrew E. ;
Nielsen, G. Petur ;
Desphpande, Vikram ;
Suit, Herman D. ;
DeLancy, Thomas F. ;
Yoon, Sam S. .
ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (06) :1953-1967
[2]  
D'Adamo DR, 2007, J CLIN ONCOL, V25
[3]   Selected combination therapy with sorafenib: A review of clinical data and perspectives in advanced solid tumors [J].
Dal Lago, Lissandra ;
D'Hondt, Veronique ;
Awada, Ahmad .
ONCOLOGIST, 2008, 13 (08) :845-858
[4]   A 14-year retrospective review of angiosarcoma: Clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy [J].
Fury, MG ;
Antonescu, CR ;
Van Zee, KJ ;
Brennan, MF ;
Maki, RG .
CANCER JOURNAL, 2005, 11 (03) :241-247
[5]  
Jonasch E, 2007, J CLIN ONCOL, V25
[6]   Cutaneous angiosarcoma [J].
Mendenhall, William M. ;
Mendenhall, Charles M. ;
Werning, John W. ;
Reith, John D. ;
Mendenhall, Nancy P. .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (05) :524-528
[7]   Cutaneous angiosarcoma: A case series with prognostic correlation [J].
Morgan, MB ;
Swann, M ;
Somach, S ;
Eng, W ;
Smoller, B .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (06) :867-874
[8]   Cutaneous angiosarcoma of the scalp - A multidisciplinary approach [J].
Pawlik, TM ;
Paulino, AF ;
Mcginn, CJ ;
Baker, LH ;
Cohen, DS ;
Morris, JS ;
Rees, R ;
Sondak, VK .
CANCER, 2003, 98 (08) :1716-1726
[9]   Angiosarcoma [J].
Vogt, T. .
HAUTARZT, 2008, 59 (03) :237-248
[10]   BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis [J].
Wilhelm, SM ;
Carter, C ;
Tang, LY ;
Wilkie, D ;
McNabola, A ;
Rong, H ;
Chen, C ;
Zhang, XM ;
Vincent, P ;
McHugh, M ;
Cao, YC ;
Shujath, J ;
Gawlak, S ;
Eveleigh, D ;
Rowley, B ;
Liu, L ;
Adnane, L ;
Lynch, M ;
Auclair, D ;
Taylor, I ;
Gedrich, R ;
Voznesensky, A ;
Riedl, B ;
Post, LE ;
Bollag, G ;
Trail, PA .
CANCER RESEARCH, 2004, 64 (19) :7099-7109
1